Skip to main content
Quest Diagnostics

Severe Topical Corticosteroid Withdrawal Syndrome or Enigmatic Drug Eruption?

Severe topical corticosteroid withdrawal syndrome or enigmatic drug eruption?

Authors: Tracy A, Durrani S, Mir A.

J Allergy Clin Immunol Pract. 2022 Apr;10(4):1125-1126. doi: 10.1016/j.jaip.2022.01.034.

Specialties: Dermatology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath Diagnostics, a subsidiary of Quest Diagnostics.

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.